We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
Updated: 12/31/1969
A Phase 1, Open-label, Single-dose, Dose-escalation, Safety, Tolerability, and PK Study of Intravitreal ANX007 in Participants With Primary Open-angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
Updated: 12/31/1969
A Phase 1, Open-label, Single-dose, Dose-escalation, Safety, Tolerability, and PK Study of Intravitreal ANX007 in Participants With Primary Open-angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Updated: 12/31/1969
A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solutions (0.25% and 0.5%) Compared to Vehicle in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Updated: 12/31/1969
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated: 12/31/1969
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Updated: 12/31/1969
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Updated: 12/31/1969
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated: 12/31/1969
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Updated: 12/31/1969
Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Updated: 12/31/1969
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Status: Enrolling
Updated: 12/31/1969
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Updated: 12/31/1969
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100
Updated: 12/31/1969
Pilot Comparative Study of the Kowa OCT Bi-μ and the Optovue iVue 100
Status: Enrolling
Updated: 12/31/1969
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100
Updated: 12/31/1969
Pilot Comparative Study of the Kowa OCT Bi-μ and the Optovue iVue 100
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing the Ocular Surface Prior to Cataract Surgery
Updated: 12/31/1969
Optimizing the Ocular Surface Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Optimizing the Ocular Surface Prior to Cataract Surgery
Updated: 12/31/1969
Optimizing the Ocular Surface Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium
Updated: 12/31/1969
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium
Updated: 12/31/1969
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)
Updated: 12/31/1969
A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD
Status: Enrolling
Updated: 12/31/1969
Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)
Updated: 12/31/1969
A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Updated: 12/31/1969
Evaluation of Approved and Investigational Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials